Diversified Healthcare Trust
NASDAQ:DHCREIT - Healthcare Facilities
+$0.25 today
- Market cap
- $1.76B
- Beta
- 2.29
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.33
- Dividend yield
- 0.45%
Volume 1.69M
Average 1.79M
DHC Interest Expense
Cost of servicing the company's debt during the period.
Diversified Healthcare TrustNASDAQ: DHC
Interest Expense · Q1 FY2026 · quarter ended Mar 2026
Interest expense declines year over year
Q1 FY2026 interest expense of $37.03M fell 36.0% year over year, behind the -1.2% change in trailing-twelve-month interest expense. Sequentially, it fell 61.0% from the prior quarter. Over 3 fiscal years it compounded at -0.8% a year.
Context
- Interest expense amounted to 13.3% of revenue in FY2025, down 2.4 pp from a year earlier.
- Interest expense increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -36.0% toward the trailing-twelve-month pace of -1.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 204.5M USD
- Year-over-year change
- -13.1%
- 4-year CAGR
- -5.4%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 204.5M | -13.1% |
| FY2024 | 2024-12-31 | 235.24M | +22.7% |
| FY2023 | 2023-12-31 | 191.78M | -8.4% |
| FY2022 | 2022-12-31 | 209.38M | -18.1% |
| FY2021 | 2021-12-31 | 255.76M | — |
Interest Expense vs competitors
How DHC compares with its peers on the latest reported figures
- DHC's LTM Mar 2026 interest expense of $232.58M is the 4th highest of the 7 companies compared; the peer median is $310.55M.
- Its year-over-year change of -1.2% is the 5th highest of 7, against a peer median of +1.9%.
- Interest expense amounts to 15.3% of revenue for DHC, versus a peer median of 41.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $968.01M | +33.5% | +28.5% | 68.9% | |
| LTM Mar 2026 | $523.75M | +1.7% | +25.7% | 73.1% | |
| LTM Mar 2026 | $454.39M | -21.6% | +23.9% | 59.4% | |
| LTM Mar 2026 | $232.58M | -1.2% | -0.8% | 15.3% | |
| LTM Mar 2026 | $166.71M | -3.3% | +4.7% | 20.5% | |
| LTM Mar 2026 | $127.67M | +2.2% | +24.9% | 22.6% | |
| LTM Mar 2026 | $45.72M | +21.2% | +10.7% | 16.8% | |
| Peer median (excluding DHC) | $310.55M | +1.9% | +24.4% | 41.0% | |
Competitors are the stored peer set for DHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.28B | 1.41B | 1.5B | 1.54B |
| Cost of Revenue | 1.09B | 1.11B | 1.19B | 1.24B | 1.78B |
| Gross Profit | 291.4M | 174.5M | 225.3M | 256.38M | (245.33M) |
| Gross Margin | 21.1% | 13.6% | 16.0% | 17.1% | -16.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.09M | 26.44M | 26.13M | 26.52M | 45.5M |
| Operating Expenses | 305.22M | 265.72M | 26.13M | 26.52M | (206.07M) |
| Depreciation & Amortization | 271.13M | 239.53M | 283.84M | 285.06M | 261.92M |
| EBITDA | 708.25M | 427.79M | 198.93M | 229.96M | 182.28M |
| EBITDA Margin | 51.2% | 33.3% | 14.1% | 15.4% | 11.9% |
| Operating Income | (13.82M) | (91.22M) | 199.17M | 229.86M | (39.27M) |
| Operating Margin | -1.0% | -7.1% | 14.1% | 15.4% | -2.6% |
| Interest Income | 20.64M | 15.93M | 15.54M | 8.95M | 0 |
| Interest Expense | 255.76M | 209.38M | 191.78M | 235.24M | 204.5M |
| Other Income / Expenses | 195.17M | 76.16M | (492.3M) | (599.65M) | (244.88M) |
| Income Before Tax | 181.36M | (15.06M) | (293.13M) | (369.79M) | (284.14M) |
| Pre-Tax Margin | 13.1% | -1.2% | -20.8% | -24.7% | -18.5% |
| Income Tax Expense | 1.43M | 710K | 445K | 467K | 1.74M |
| Net Income | 174.52M | (15.77M) | (293.57M) | (370.26M) | (285.89M) |
| Net Margin | 12.6% | -1.2% | -20.8% | -24.8% | -18.6% |
| EPS (Basic) | 0.73 | (0.07) | (1.23) | (1.55) | (1.19) |
| EPS (Diluted) | 0.73 | (0.07) | (1.23) | (1.55) | (1.19) |
| Weighted Avg Shares | 237.97M | 238.32M | 238.84M | 239.54M | 240.29M |
| Weighted Avg Shares (Diluted) | 237.97M | 238.31M | 238.84M | 239.54M | 240.29M |
Diversified Healthcare Trust
NASDAQ:DHC
Intrinsic Alpha fair value
Locked
Current Price
$7.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.